Evotec SE EVO
NASDAQ EVO
$1.42 +0.08 (+5.95%)
At close: Oct 14, 2026 · 4:00 PM EDT

Evotec SE (EVO) Non-Current Deffered Revenue (2009 - 2026)

Updated

Evotec SE (EVO) posted Non-Current Deffered Revenue of -$205.8 million for the quarter ended Jun 30, 2022.

Analysis

Evotec SE (EVO) Non-Current Deffered Revenue (2009 - 2026) Analysis & Trends

As of Dec 31, 2021, Evotec SE's Non-Current Deffered Revenue came in at -$39.62 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn -
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn -
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn -
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn -
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn 76.54 Mn
7 Evotec SE 506.10 Mn -1.10 Bn - 156.15 Mn
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn -
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn -
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.15 Mn
Mar 31, 2026 151.36 Mn
Dec 31, 2025 170.72 Mn
Sep 30, 2025 198.66 Mn
Jun 30, 2025 190.25 Mn
Mar 31, 2025 210.39 Mn
Dec 31, 2024 163.04 Mn
Sep 30, 2024 232.56 Mn
Dec 31, 2023 171.87 Mn
Jun 30, 2023 238.72 Mn
Dec 31, 2022 219.76 Mn
Sep 30, 2022 176.90 Mn
Jun 30, 2022 -201.48 Mn
Mar 31, 2022 35.58 Mn
Dec 31, 2021 37.91 Mn
Sep 30, 2021 30.86 Mn
Dec 31, 2020 27.60 Mn
Sep 30, 2010 1.68 Mn
Jun 30, 2010 463,517.88
Mar 31, 2010 1,527.76
API Access

Evotec SE Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EVO&period=max&api_key=YOUR_API_KEY